Xavier Bosch
Impact in
- Epidemiology top 2%
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
Papers in
-
- Reproductive tract infections research 5
-
- Endometrial and Cervical Cancer Treatments 7
- Co-authors
- Núbia MuñózJan M.M. WalboomersSilvia de SanjoséXavier CastellsaguéCarlos A. GonzálezReina García-ClosasLaia AlemanySilvia Franceschi
- Journals
- The Lancet Oncology (11 papers)The Lancet (7 papers)International Journal of Cancer (5 papers)Journal of Lower Genital Tract Disease (3 papers)Human Vaccines & Immunotherapeutics (2 papers)
- Partner nations
- SpainUnited StatesNetherlands
In The Last Decade
Xavier Bosch
60 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 128
- Epidemiology 1.1k
- Otorhinolaryngology 124
- Hepatology 209
- Microbiology 105
- Oncology 333
Countries citing papers authored by Xavier Bosch
This map shows the geographic impact of Xavier Bosch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Bosch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Bosch more than expected).
Fields of papers citing papers by Xavier Bosch
This network shows the impact of papers produced by Xavier Bosch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Bosch. The network helps show where Xavier Bosch may publish in the future.
Co-authors
The 25 scholars most cited alongside Xavier Bosch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2022 | 11 | |
| 3 | 2019 | 20 | |
| 4 | 2019 | 51 | |
| 5 | 2015 | 10 | |
| 6 | Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome. | 2013 | 37 |
| 7 | 2013 | 8 | |
| 8 | 2012 | 47 | |
| 9 | 2011 | 9 | |
| 10 | 2011 | 16 | |
| 11 | 2011 | 1 | |
| 12 | 2011 | 6 | |
| 13 | 2010 | 56 | |
| 14 | 2008 | 32 | |
| 15 | 2007 | 8 | |
| 16 | 2006 | 46 | |
| 17 | 2004 | 33 | |
| 18 | 2000 | 103 | |
| 19 | 1998 | 11 | |
| 20 | 1996 | 118 |
About Xavier Bosch
Xavier Bosch is a scholar working on Microbiology, Obstetrics and Gynecology, Epidemiology, Oncology and Surgery, having authored 62 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (24 papers), Genital Health and Disease (12 papers), Endometrial and Cervical Cancer Treatments (7 papers), Hepatitis B Virus Studies (7 papers), Reproductive tract infections research (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Vaccine Coverage and Hesitancy (3 papers) and Molecular Biology Techniques and Applications (3 papers). The work is most often cited by research in Epidemiology (1.1k citations), Otorhinolaryngology (124 citations), Hepatology (209 citations), Microbiology (105 citations) and Oncology (333 citations). Xavier Bosch has collaborated with scholars based in Spain, United States and Netherlands. Frequent co-authors include Núbia Muñóz, Jan M.M. Walboomers, Silvia de Sanjosé, Xavier Castellsagué, Carlos A. González, Reina García-Closas, Laia Alemany, Silvia Franceschi, Peter J.F. Snijders and John Kaldor. Their work appears in journals such as The Lancet Oncology, The Lancet, International Journal of Cancer, Journal of Lower Genital Tract Disease and Human Vaccines & Immunotherapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.